Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Changes in CD4 Lymphocyte Count in Patients With a HAART Regimen Including DDI + Tenofovir and With Viral Suppression Following the Replacement of Tenofovir With Abacavir Once Daily or Following the Double Replacement of DDI + Tenofovir With Abacavir + Lamivudine in a Single Tablet

NCT00338390 is registered in ClinicalTrials.gov with Hospital de Granollers as lead sponsor.

NCT NCT00338390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00338390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Changes in CD4 Lymphocyte Count in Patients With a HAART Regimen Including DDI + Tenofovir and With Viral Suppression Following the Replacement of Tenofovir With Abacavir Once Daily or Following the Double Replacement of DDI + Tenofovir With Abacavir + Lamivudine in a Single Tablet
Lead sponsor
Hospital de Granollers
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
February 28, 2007
Enrollment
75 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections